Mean adhesion score at second‐look laparoscopy · women having gynaecological surgery
1 finding from 1 review
Clinical pregnancy rate · women having gynaecological surgery
Hydroflotation agents showed no clear difference in clinical pregnancy rate compared with no hydroflotation agents (or placebo) (moderate certainty).
1 finding from 1 review
Adverse events · women having gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pelvic pain · women having gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women having gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of adhesions at second‐look laparoscopy · women having gynaecological surgery
Gel agents leads to lower incidence of adhesions at second‐look laparoscopy compared with no gel agents (or placebo) (high certainty).
1 finding from 1 review
Pelvic pain · women having endometriosis surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence · women having endometriosis surgery
Postsurgical medical therapy may leads to lower disease recurrence ≤ 12 months (dichotomous) compared with placebo or no medical therapy (low certainty).
1 finding from 1 review
Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery
It is very uncertain whether postsurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pregnancy rate · women having endometriosis surgery
Postsurgical medical therapy probably leads to higher pregnancy rate (dichotomous) compared with placebo or no medical therapy (moderate certainty).
1 finding from 1 review
Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Disease recurrence at 3 months – total (AFS score) · women having endometriosis surgery
1 finding from 1 review
Recurrence · women having endometriosis surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease recurrence ≤ 12 months (EEC stage) · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes disease recurrence ≤ 12 months (EEC stage) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pregnancy rate · women having endometriosis surgery
It is very uncertain whether presurgical medical therapy changes pregnancy rate (dichotomous) compared with placebo or no medical therapy (very low certainty).
1 finding from 1 review
Pelvic pain · women having endometriosis surgery
1 finding from 1 review
Pain recurrence (dichotomous) Pain recurrence ≤ 12 months · women having endometriosis surgery
Postsurgical medical therapy may leads to lower pain recurrence (dichotomous) Pain recurrence ≤ 12 months compared with placebo or no medical therapy (low certainty).
1 finding from 1 review
Disease recurrence at 12 months – total (AFS score) · women having endometriosis surgery
1 finding from 1 review
Live birth rate per woman ‐ long protocol GnRH‐agonist · women with polycystic ovary syndrome
Metformin showed no clear difference in live birth rate per woman ‐ long protocol GnRH‐agonist compared with placebo or no treatment (low certainty).
1 finding from 1 review
Live birth rate per woman ‐ short protocol GnRH‐antagonist · women with polycystic ovary syndrome
Metformin may leads to lower live birth rate per woman ‐ short protocol GnRH‐antagonist compared with placebo or no treatment (low certainty).
1 finding from 1 review